loader2
Partner With Us NRI

Company details

6.70
7.18
6.51
15.97
6M Return -30.44%
1Y Return -41.94%
Mkt Cap.(Cr) 25.98
Volume 5,645
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 5,645

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 32.85 Cr FV: 2.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 23,081.38 -37,247.74
LAST 3M 71,111.08 -54,074.79
LAST 6M 141,746.37 -188,969.09
LAST 12M 212,995.89 -183,256.64

Information

  • About Company
  • Company Info
  • Listing Info
0
36.94%
9.363
0%
0%
Description
  • Vista Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the formulation of pharmaceutical products. The company offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd. The company is based in Hyderabad, India. Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America. During the fiscal year ended March 31, 2010 (fiscal 2010), the Company obtained the United States Food and Drug Administration (FDA) approval for the manufacture of Bactrim generic product. During fiscal 2010, the Company produced 20.488 million numbers of tablets. The Company was in process of setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.

Read More

Registered Address

Plot No 10to14 16to20 APIIC, Industrial Estate Chotyal, Nalgonda, Telangana,

Tel : 91-09291015956
Email : admin.hyd:vistapharmaceuticals.com
Website : http://www.vistapharmaceuticals.com

Registrar

Aarthi Consultants Pvt Ltd

AGM Date (Month) : Dec
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 524711
NSE Code :
Book Closure Date (Month) :
BSE Group : XT
ISIN : INE427C01021

ICICIdirect Vista Pharmaceuticals Ltd FAQ

You can buy Vista Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vista Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 27, 2022 04:01 PM the closing price of Vista Pharmaceuticals Ltd was ₹ 7.06.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 27, 2022 04:01 PM, the market cap of Vista Pharmaceuticals Ltd stood at ₹ 25.98.
The latest PE ratio of Vista Pharmaceuticals Ltd as of May 27, 2022 04:01 PM is 0
The latest PB ratio of Vista Pharmaceuticals Ltd as of May 27, 2022 04:01 PM is 1.33
The 52-week high of Vista Pharmaceuticals Ltd is ₹ 15.97 while the 52-week low is ₹ 6.51 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE